Ainos, Inc. AIMD
Set alert
0.63 USD -0.10 -13.77%
At close · Oct 30
0.63 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
0.5601 Day range 0.6898
0.6286 52-week range 3.38
- YTD
- -61.67%
- 1 year
- -81.35%
- Open
- 0.6898
- Prev close
- 0.729
- Mkt cap
- 4.64M
- Vol
- 30.56K
- Avg vol
- 189.19K
- EPS
- -2.54
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5601
- High
- 0.6898
- Forward P/E
- 0.00
- Beta
- 1.41
- Short ratio
- 0.89
- Inst. own
- 1.34%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.4748
- 200-d avg
- 0.74847
- 1y target
- 0.00
6M chart
Signals (31)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| RSI: Oversold | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 16, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 16, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 9, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| SMA: Bearish | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| SMA: Bearish | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| SMA: Bearish | Jun 18, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 4 months ago |
| SMA: Bullish | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 26, 2026 | 5 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| RSI: Overbought | May 26, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
Key statistics
- Market cap
- 6.80M
- Enterprise value
- 13.36M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 167.25
- Price / book
- 0.36
- EPS (TTM)
- -2.71
- Beta
- 1.41
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 40.63K
- Revenue growth
- 0.00%
- Free cash flow
- 621.86K
- Total cash
- 5.16M
- Total debt
- 12.27M
- Return on equity
- -70.60%
- Shares outstanding
- 14.54M
- Short % of float
- 1.44%
- 50-day average
- 0.4748
- 200-day average
- 0.74847
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
AIMD Revenue — quarterly 152
AIMD Net income — quarterly -4.59M
AIMD EPS — quarterly -0.62
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | 0.00 | -0.33 | — | — |
| Aug 5, 2024 | Jun 1, 2024 | 0.00 | -0.49 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -0.57 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -0.75 | — | — |
| Aug 11, 2023 | Jun 1, 2023 | 0.00 | -0.60 | — | — |
| May 12, 2023 | Mar 1, 2023 | 0.00 | -0.65 | — | — |
About Ainos, Inc.
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- ainos.com
News
- Ainos Announces AI Nose Platform Hits Over 3B Chemical Data Points
- 12 Information Technology Stocks Moving In Thursday's After-Market Session
- Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
- Ainos Completes Required Data Delivery And Technology Transfer Under Its VELDONA License Deal For $600K Initial License Payment
- Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment
- Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year Contract
- Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence
- Ainos, Inc. (NASDAQ:AIMD) Shares Shorted: Short Interest Up 172.6% in September
- 12 Information Technology Stocks Moving In Thursday's Pre-Market Session
- Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework
Your note
Sign in to keep a note on AIMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHANG WEN-HAN | Director | Conversion of Exercise of derivative security | Jan 30, 2024 | 106,265 |
| CHIANG YAO-CHUNG | Director | Conversion of Exercise of derivative security | Jan 30, 2024 | 54,932 |
| LEE HSIN LIANG CHRISTOPHER | Chief Financial Officer | Conversion of Exercise of derivative security | Nov 25, 2024 | 22,376 |
| LEE TING CHUAN | Director | Conversion of Exercise of derivative security | Nov 25, 2024 | 327,432 |
| LIN LAWRENCE K | Officer | Conversion of Exercise of derivative security | Feb 15, 2024 | 11,260 |
| SUNG MENG-LIN | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 15, 2024 | 61,050 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 0.48% | 67,007 | 31.31K | Sep 29, 2024 |
| Virtu Financial LLC | 0.33% | 45,221 | 21.13K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.17% | 23,321 | 10.90K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.17% | 24,058 | 11.24K | Sep 29, 2024 |
| Blackrock Inc. | 0.11% | 15,325 | 7.16K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.06% | 8,763 | 4.09K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.14% | 19,951 | 9.32K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.02% | 3,305 | 1.54K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.01% | 1,966 | 918 | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 1,980 | 925 | Oct 30, 2024 |